Mariner
TSVT

Mariner’s 2seventy bio TSVT Stock Holding History

Mariner’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,196
Closed -$67.1K – 3514
2024
Q3 		$67.1K Sell
14,196
-200
-1% -$902 ﹤0.01% 3155
2024
Q2 		$55.4K Sell
14,396
-100
-0.7% -$451 ﹤0.01% 3037
2024
Q1 		$77.6K Sell
14,496
-279
-2% -$1.31K ﹤0.01% 2974
2023
Q4 		$63.1K Sell
14,775
-1,285
-8% -$3.95K ﹤0.01% 2918
2023
Q3 		$63K Buy
16,060
+2,899
+22% +$19K ﹤0.01% 2742
2023
Q2 		$133K Sell
13,161
-5,308
-29% -$56.2K ﹤0.01% 2576
2023
Q1 		$188K Buy
18,469
+5,555
+43% +$63.5K ﹤0.01% 2433
2022
Q4 		$121K Buy
+12,914
New +$182K ﹤0.01% 2476

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return

Mariner's TSVT Position: Q4 2024 in Review

Mariner sold out of 2seventy bio (TSVT) in Q4 2024, closing a stake of 14,196 shares — an estimated $67.1K sold.

Mariner first reported a position in TSVT in Q4 2022 and held it in 8 quarters. The position peaked at $188K in Q1 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2024.

  • Mariner reported no remaining 2seventy bio position as of Q4 2024 after selling out during the quarter.
  • Mariner sold 14,196 2seventy bio shares in Q4 2024, an estimated $67.1K.
  • Mariner first reported a position in 2seventy bio in Q4 2022 and held it in 8 quarters.
  • Mariner's 2seventy bio position peaked at $188K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.